TMDX
Transmedics Group Inc
$68.98-5.19%
Setup
No setup
Buy Zone
$66.71-$70.05
Sector
Medical Devices
Industry
Medical Devices
29
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
TMDX chart
Loading chart…
ADX
Weak or Absent15.1Long Term
Range →Intermediate Term
Range →Short Term
Up ↑Overall Quality29
RS Rating
6
relative strength
Fundamentals
57
Weak fund-Q
Volume Demand
68
+103% vs avg
Technical Setup
25
2/8 checks
Industry/Theme
91
Medical Devices
Trade Plan
Avoid
Entry
$66.71
Entry Zone
$66.71-$70.05
Stop / Risk
$61.37
RS Rating
6
Volume confirmed
No
Targets
$80.05 / $83.39
Breakout · IBD Setup
1 ✓ 7 ✗
Entry $66.71–$70.05Stop $61.37Target $80.05 / $83.39
Market regimeRange
Quality29
RS Rating6
Above 50-MA-13.43%
Above 200-MA-25.86%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
29
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q57 · Weak
StatusAvoid
Stock Data
52-Week Range60 – 156
Price % Chg YTD-43.3%
Price % Chg 4wk-14.91%
50-Day Avg Vol0.8 Mil
P/E Ratio17.2
Market Cap$2B
SectorHealthcare
IndustryMedical Devices
Company Fundamentals
EPS % Chg (Qtr)-55.84%
Sales % Chg (Qtr)20.7%
EPS Growth 5y—
Sales Growth 5y88.21%
Annual ROE36.28%
Gross Margin57.75%
Operating Margin12.21%
Net Margin22.69%
Debt / Equity1.67
Setup levels
Current price
$68.98
Pivot
$66.71
Distance to buy
-55.8%
52-week range
60.1-155.99
Trigger evidence
No active trigger evidence available.
Financial health checks
3/5
Return on equity above 15%
ROE 36.28%
Net margin above 10%
Net margin 22.69%
EPS growing quarter on quarter
EPS q/q -55.84%
Sales growing quarter on quarter
Sales q/q 20.7%
Debt to equity below 1.0
D/E 1.67
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE36.28%
vs sector +13.7%
Net margin22.69%
vs sector +5.0%
Gross margin57.75%
vs sector -9.4%
EPS growth q/q-55.84%
vs sector -63.4%
Sales growth q/q20.7%
vs sector +2.0%
Debt / equity1.67
vs sector +1.02
Business quality
57
GradeWeak
EPS rating13
P/E17.2
Market cap$2B
IndustryMedical Devices
Technical checks
Über 50-MA
Fail
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-11-02
Trigger date
—
Days on list
4
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.